Northwire Canada EditionFriday, July 10, 2026
Northwire
ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.73 +9.3% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2% ABX 51.91 −0.6% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.73 +9.3% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2%
Regulatory Routine +

Curaleaf Announces Results of its 2026 Shareholders Meeting

Governance cleanup clears the path for a U.S. exchange listing; administrative filing delivers no new financial catalysts to re-rate the stock.

Executive Summary
  • Shareholders approved a plan of arrangement to reincorporate the company from British Columbia to Delaware.
  • Shareholders approved an amendment to remove the automatic conversion feature of Multiple Voting Shares upon listing on a major U.S. exchange (Nasdaq/NYSE).
  • Shareholders approved an option exchange program converting up to 10,070,478 stock options (exercise price/vesting tied to share price ≥ $5.00) into restricted share units (RSUs).
  • All seven nominated directors were re-elected with overwhelming support (>97% for each).
  • Next steps include filing the articles amendment, implementing the option exchange program by June 30, 2026, and attending a court hearing on June 25, 2026, to finalize the reincorporation.
  • This is a standard corporate governance and capital structure update designed to facilitate a potential uplisting to a major U.S. exchange following cannabis rescheduling.
Material Impact
  • The news is Routine - Positive. It is a necessary administrative step to facilitate a U.S. exchange uplisting, which management has telegraphed multiple times. The market reaction (flat price action) confirms this was expected. The material catalyst remains the actual U.S. listing and Q2 earnings, not this governance cleanup.
CURA · Price
Company Overview
  • Curaleaf Holdings is a leading multi-state operator (MSO) in the U.S. cannabis market, with a footprint of 165+ dispensaries across 15+ states. It also operates internationally in Germany, the UK, Poland, and Australia. The company focuses on vertically integrated cultivation, manufacturing, and retail, with a strong emphasis on premium brands (Dark Heart, Select Briq 2) and wholesale distribution.
Read the original news release →

More from CURALEAF HOLDINGS, INC. J